• Cellbion CSO Jeong Jae Min acquired 10,149 common shares through stock option exercise on Nov. 12, 2026.
• The exercise price was 9,360 won per share, bringing his stake to 0.07% as of Nov. 13.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellbion Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000050), on November 13, 2026, and is solely responsible for the information contained therein.